Journal of Biosensors & Bioelectronics is a quarterly publisher which provides the rapid publication of articles in all areas related to Biosensors, Chemical sensor, Bioelectronics, Immuno sensors, Integrated nanoscale devices, Molecular recognition biomolecules, Microfluidics biosensors, Neural sensor, Array biosensor, Bioactuators and many more.Journal of Biosensors & Bioelectronics welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence. Papers will be published approximately one month after acceptance.
Submit manuscript at https://www.scholarscentral.org/submissions/biosensors-bioelectronics.html or send as an e-mail attachment to the Editorial Office at [email protected]
A manuscript number will be e-mailed to the corresponding author within 72 hours.
Ethical standards of very high-quality ensures the authenticity of the scientific publication and wins the public trust on scientific findings so that it enhances the credibility of the research work or idea.
Hilaris considers only the original research work that has neither been published elsewhere, nor under process of reviewing for publication. Hilaris deploys authenticated software tool to detect similar and overlapping of information in the submitted documents. Information that is found to have been plagiarized from the manuscripts of other authors would be summarily rejected, involving thorough changes as suggested by the reviewers.
A publication that overlaps or relates substantially with any other article that is already published, in press, or under consideration/submission is considered as Duplicate or redundant publication. Duplicate or redundant submission is identical manuscript (or having the similar data) that is submitted to various journals for publication. International copyright laws, ethical conducts, and cost effective use of resource ensure originality of the manuscript submitted.
Manuscripts must be original and should not have published or submitted elsewhere while its under consideration for publication with a publisher. According to the APA code of ethics (APA Publication Manual, 2010) duplicate publication is violation of publication ethics and will be rejected.
If the author has any doubts related to re-using of a figure published elsewhere or that has been copyrighted, then s/he should seek advice from the editorial board members that is handling their manuscript. In such cases, he author must provide documentation from the previous publisher or the copy right holder’s permission for the figure to be re-published. In case if the author was not aware of the violation of the code and the material has been published, then measures must be taken to correct the same by submitting the manuscript with necessary amendments to rectify the ethical violation.
Any Submitted document which is found to contain citations with a motto to increase the number of citations of a given author, it will be considered as citation manipulation.
Data Falsification or Fabrication
If the submitted documents are identified as fabricated or falsified with the experimental results consisting manipulated images, it is considered as falsification or fabrication consents.
Incorrect Author Contribution
All listed or mentioned authors should have made a significant contribution towards the research work submitted and should be approving all its claims. It is necessary to list out the specific individual that made significant contribution, including the students or any laboratory technicians.
Conflicts of interest
In order to maintain transparency and help readers to form their own judgements of potential bias, authors should declare any competing financial interests related to the work described or presented.
During submission, policy entails that every author should reveal financial interests or collaborations, which may be direct or indirect and may raise the question of conflict or bias in the submitted work or in the conclusions, opinions given or implications, or any other sources of funding for related direct or indirect academic competition.
However, in the case of accepted manuscript, Conflict of Interest information should be mentioned as a statement in the document.
Permissions to reproduce previously published material
Permission is essential to reproduce material from the copyright holder. Articles cannot be directly published without these permissions.
Patient consent forms
It is very essential to protect patient’s right to privacy. Kindly collect and preserve copies of patient’s consent forms that mention patients or other themes of your experiments clearly. Take enough care to protect their identities while submitting the document for publication as photographs or any other material that may recognise them. If the consent forms are not obtained, then, it is requested to obtain one or to remove the elements that may reveal the individual identities from the document. However, the obtained statement must be included in the ‘Methods’ section of your manuscript. If required the Editors may request a copy of the consent forms.
Ethics committee approval
All the manuscripts dealing with the original human or animal data should include a statement on ethics approval at the commencement of the Methods section. Also, should contain the mentioned information: the name and the address of the responsible ethics committee, the protocol number, along with the date of approval that is attributed by the ethics committee mentioned.
The paragraph can declaim, for example:
"Ethical approval for this study was given by the Ethical Committee of specific University or Hospitals, of certain place, on specific date."
Furthermore, as detailed above for the studies carried on human participants, it is necessary to state evidently that you have obtained the written consent from the participants that s/he has read and understood the details and they are participating in it with their personal consent. Kindly, refer the latest version of the Declaration given by the specific organization. Similarly, experiments that involve animals, you must provide the state of animal care and licensing guidelines under which the study was performed and is reported. This should be provided in accordance with the ARRIVE statement (Animals in Research: Reporting In Vivo Experiments). In any case, if ethics clearance was not obligatory or if there was any deviation or change from the standard of ethical requests, it is required to state the specified reason. Though, please note that the editor/s might ask you to provide evidence of ethical approval. Besides, If you have approval from a National Drug Agency (or similar) please state this and provide details, this can be particularly useful when discussing the use of unlicensed drugs.
HILARIS SRL Policy Regarding the NIH Mandate
HILARIS SRL will support authors by posting the published version of articles by NIH grant-holders to PubMed Central immediately after publication.
Editorial Policies and Process
The Journal of Biosensors & Bioelectronics follows a progressive Editorial Policy that encourages innovation and analysis to submit the initial research, reviews and editorial observations as articles, well supported by tables and graphic illustration.
Note: Authors are sole responsible for any scientific misconduct including plagiarism in their research articles; publisher is not responsible for any scientific misconduct happened in any published research article. As a publisher we will follow strictly scientific guidelines and EIC’s advice to retract or erratum of any article at any time if scientific misconduct or errors happened in any articles.
Article Processing Charges (APC) :
Journal of Biosensors & Bioelectronics is organized by HILARIS SRL, a self supporting organization and does not receive funding from any institution/government. Hence, the operation of the Journal is solely financed by the handling fees received from authors and some academic/corporate sponsors. The handling fees are required to meet maintenance of the journal. Being an Open Access Journal, Journal of Journal of Biosensors & Bioelectronics does not receive payment for subscription, as the articles are freely accessible over the internet. Authors of articles are required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication.
Average Article prorcessing time (APT) is 55 days
The article processing charge for authors funded by Government or any Research Grant is $3619. Payment must be received in full for the article to be published open access.
In order to reduce delays, authors should assure that the level, length and format of a manuscript submission conform to HILARIS SRL requirements at the submission and each revision stage. Submitted articles should have a summary/abstract, separate from the main text, of up to 300 words. This summary does not include references, numbers, abbreviations or measurements unless essential. The summary should provide a basic-level introduction to the field; a brief account of the background and principle of the work; a statement of the main conclusions; and 2-3 sentences that place the main findings into a general context. The text may contain a few short subheadings of no more than 40 characters each. HILARIS SRL to accomplish its vision to make scientific information & health care open access, has made a new initiation to enrich the scientific knowledge all around the world. As per the interest of the scientific community from Non-English speaking territories, we have introduced a new feature in the name of language translation. Language translation helps the scientific community to go through the articles in Chinese, Japanese & other world languages.
Formats for HILARIS SRLInternational Contributions: HILARIS SRL accepts the following: original articles, reviews, abstracts, addendums, announcements, article-commentaries, book reviews, rapid communications, letters to the editor, annual meeting abstracts, conference proceedings, calendars, case-reports, corrections, discussions, meeting-reports, news, obituaries, orations, product reviews, hypotheses and analyses.
Cover Letter: All submissions should be accompanied by a 500 words or less cover letter briefly stating the significance of the research, agreement of authors for publication, number of figures and tables, supporting manuscripts, and supplementary information. Also, include current telephone and fax numbers, as well as postal and E-mail address of corresponding author to maintain communication.
Article Preparation Guidelines Manuscript title: The title should be limited to 25 words or less and should not contain abbreviations. The title should be a brief phrase describing the contents of the paper.
Author Information: Complete names and affiliation of all authors, including contact details of corresponding author (Telephone, Fax and E-mail address).
Abstract: The abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should summarize the manuscript content in 300 words or less. Standard nomenclature should be used and abbreviations should be avoided. The preferable format should accommodate a description of the study background, methods, results and conclusion. Following the abstract, a list of keywords (3-10) and abbreviations should be included.
Text: Introduction: The introduction should set the tone of the paper by providing a clear statement of the study, the relevant literature on the study subject and the proposed approach or solution. The introduction should be general enough to attract a reader’s attention from a broad range of scientific disciplines.
Materials and Methods: This section should provide a complete overview of the design of the study. Detailed descriptions of materials or participants, comparisons, interventions and types of analysis should be mentioned. However, only new procedures should be described in detail; previously published procedures should be cited and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address.
Results: The results section should provide complete details of the experiment that are required to support the conclusion of the study. The results should be written in the past tense when describing findings in the authors'experiments. Previously published findings should be written in the present tense. Results and discussion may be combined or in a separate section. Speculation and detailed interpretation of data should not be included in the results but should be put into the discussion section.
Acknowledgment: This section includes acknowledgment of people, grant details, funds, etc.
Note: If an author fails to submit his/her work as per the above instructions, they are pleased to maintain clear titles namely headings, subheading.
References: Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. All personal communications should be supported by a letter from the relevant authors. HILARIS SRL uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. When there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]". Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Figure captions and tables should be at the end of the manuscript. Authors are requested to provide at least one online link for each reference as following (preferably PubMed). Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:
Examples: Published Papers:
Note: Please list the first five authors and then add "et al." if there are additional authors. Electronic Journal Articles Entrez Programming Utilities
Tables: These should be used at a minimum and designed as simple as possible. We strongly encourage authors to submit tables as .doc format. Tables are to be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in Arabic numerals and supplied with a heading and a legend. Tables should be self-explanatory without reference to the text. Preferably, the details of the methods used in the experiments should be described in the legend instead of in the text. The same data should not be presented in both table and graph form or repeated in the text. Cells can be copied from an Excel spreadsheet and pasted into a word document, but Excel files should not be embedded as objects.
Note: If the submission is in PDF format, the author is requested to retain the same in .doc format in order to aid in completion of process successfully.
Figures: The preferred file formats for photographic images are .doc, TIFF and JPEG. If you have created images with separate components on different layers, please send us the Photoshop files. All images must be at or above intended display size, with the following image resolutions: Line Art 800 dpi, Combination (Line Art + Halftone) 600 dpi, Halftone 300 dpi. See the Image quality specifications chart for details. Image files also must be cropped as close to the actual image as possible. Use Arabic numerals to designate figures and upper case letters for their parts (Figure 1). Begin each legend with a title and include sufficient description so that the figure is understandable without reading the text of the manuscript. Information given in legends should not be repeated in the text.
Figure legends: These should be typed in numerical order on a separate sheet
Tables and Equations as Graphics: If equations cannot be encoded in MathML, submit them in TIFF or EPS format as discrete files (i.e., a file containing only the data for one equation). Only when tables cannot be encoded as XML/SGML can they be submitted as graphics. If this method is used, it is critical that the font size in all equations and tables is consistent and legible throughout all submissions.
Supplementary Information: Discrete items of the Supplementary Information (for example, figures, tables) referred to at an appropriate point in the main text of the paper. Summary diagram/figure included as part of the Supplementary Information (optional). All Supplementary Information is supplied as a single PDF file, where possible. File size within the permitted limits for Supplementary Information. Images should be a maximum size of 640 x 480 pixels (9 x 6.8 inches at 72 pixels per inch).
Proofs and Reprints: Electronic proofs will be sent as an e-mail attachment to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Authors will have free electronic access to the full text (HTML, PDF and XML) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
Copyright: Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere. All works published by HILARIS SRL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.